The global ophthalmic drug delivery systems market size is projected to reach USD 23.4 billion by 2030. The market is expected to expand at a CAGR of 8.3% from 2022 to 2030. Factors such as growing prevalence of ophthalmic diseases, rise in number of ophthalmic procedures that require attentive post procedural care and increase in need to deliver controlled dosage forms for pediatric and geriatric population are anticipated to propel the growth of the market. In addition, immense focus on technological advancements is further helping the market to grow at a significant rate. For instance, manufacturers’ instant focus on nanotechnology has helped to deliver error-free drug delivery and increase the penetration level of the drug at the target site.
The market observed a sudden fall in sales of ophthalmic drug delivery systems during the first half of the COVID-19 pandemic. The lockdowns across different countries and various restrictions led down by the government led to fall in number of patient’s visits to the hospitals and clinics. Moreover, the disruption in supply chains also led to a shortage of these products which indicates an overall negative impact on the market. However, with the government’s initiatives to curb the spread of the virus and limit the negative consequences it possesses via mass vaccination programs and heavy investment in R&D activities, the market is expected to recover over the forecast period.
The market observed a sudden fall in sales of ophthalmic drug delivery systems during the first half of the COVID-19 pandemic. The lockdowns across different countries and various restrictions led down by the government led to fall in number of patient’s visits to the hospitals and clinics. Moreover, the disruption in supply chains also led to a shortage of these products which indicates an overall negative impact on the market. However, with the government’s initiatives to curb the spread of the virus and limit the negative consequences it possesses via mass vaccination programs and heavy investment in R&D activities, the market is expected to recover over the forecast period.
Ophthalmic Drug Delivery Systems Market Report Highlights
- The eye drops segment dominated the market with highest revenue share in 2021 as eye drops are often recommended as the first line of treatment in most of the ophthalmic procedures to control the effect of the disease as it is the most convenient and patient compliant technology
- The intraocular segment held the highest revenue share in 2021 owing to the advantages it offers such as sterilization, less irritation, ease of eye drops formulation and enhancement in ocular bioavailability of drugs that are insoluble in tear fluid
- On the basis of production technology, the formulation segment accounted for highest market share in 2021 owing to increase in adoption of topical eye drops which is produced through the formulation technology
- Based on material, the hydrogels segment held the highest market share in 2021 owing to the advantages it offers over other materials
- North America accounted for highest market share in 2021 due to increasing incidence of ophthalmic disorders, presence of skilled professionals and various initiatives undertaken by the government agencies to prevent blindness in the region
- The COVID-19 pandemic has a negative impact on the market. Due to change in healthcare priorities, social distancing, worldwide lockdowns led to reduced patient visits to the hospitals and clinics
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Technology
1.1.2. Delivery Route
1.1.3. Production Technology
1.1.4. Material
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.1.1. Technology
1.1.2. Delivery Route
1.1.3. Production Technology
1.1.4. Material
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Delivery Route outlook
2.2.3. Production Technology outlook
2.2.4. Material outlook
2.2.5. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Delivery Route outlook
2.2.3. Production Technology outlook
2.2.4. Material outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Ophthalmic Drug Delivery Systems Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of eye disorders
3.4.1.2. Technological advancements
3.4.1.3. Increase in need for controlled release dosage forms for pediatric and geriatric population.
3.4.2. Market restraint analysis
3.4.2.1. Lack of trained ophthalmologists in developing nations
3.4.2.2. High cost of devices in developing nations
3.5. Ophthalmic Drug Delivery Systems Market Analysis Tools
3.5.1. Industry Analysis-Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Rising prevalence of eye disorders
3.4.1.2. Technological advancements
3.4.1.3. Increase in need for controlled release dosage forms for pediatric and geriatric population.
3.4.2. Market restraint analysis
3.4.2.1. Lack of trained ophthalmologists in developing nations
3.4.2.2. High cost of devices in developing nations
3.5. Ophthalmic Drug Delivery Systems Market Analysis Tools
3.5.1. Industry Analysis-Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Ophthalmic Drug Delivery Systems Market : Technology Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Eye drops
4.1.2. Contact lenses
4.1.3. Punctal plugs
4.1.4. Episcleral Implants
4.1.5. Intravitreal Implants
4.1.6. InjecTable Particulate Systems
4.1.7. Iontophoresis
4.1.8. Micro-Electromechanical
4.1.9. Nano careers
4.1.10. Nano microparticles
4.1.11. Microneedles
4.1.12. Hydrogels
4.1.13. Others
4.2. Technology Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Ophthalmic Drug Delivery Systems Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Eye Drops
4.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.2. Contact Lenses
4.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.3. Punctal Plugs
4.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.4. Episcleral Implants
4.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.5. Intraviteal Implants
4.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.6. InjecTable Particulate Systems
4.5.6.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.7. Iontophoresis
4.5.7.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.8. Micro-Electromechanical
4.5.8.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.9. Nano careers
4.5.9.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.10. Nano microparticles
4.5.10.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.11. Microneedles
4.5.11.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.12. Hydrogels
4.5.12.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.13. Others
4.5.13.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.1.1. Eye drops
4.1.2. Contact lenses
4.1.3. Punctal plugs
4.1.4. Episcleral Implants
4.1.5. Intravitreal Implants
4.1.6. InjecTable Particulate Systems
4.1.7. Iontophoresis
4.1.8. Micro-Electromechanical
4.1.9. Nano careers
4.1.10. Nano microparticles
4.1.11. Microneedles
4.1.12. Hydrogels
4.1.13. Others
4.2. Technology Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Ophthalmic Drug Delivery Systems Market by Technology Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Eye Drops
4.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.2. Contact Lenses
4.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.3. Punctal Plugs
4.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.4. Episcleral Implants
4.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.5. Intraviteal Implants
4.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.6. InjecTable Particulate Systems
4.5.6.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.7. Iontophoresis
4.5.7.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.8. Micro-Electromechanical
4.5.8.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.9. Nano careers
4.5.9.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.10. Nano microparticles
4.5.10.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.11. Microneedles
4.5.11.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.12. Hydrogels
4.5.12.1. Market estimates and forecast 2017 to 2030 (USD Million)
4.5.13. Others
4.5.13.1. Market estimates and forecast 2017 to 2030 (USD Million)
Chapter 5. Ophthalmic Drug Delivery Systems Market: Delivery Route Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Intraocular
5.1.2. Intravitreal
5.1.3. Intracameral
5.2. Delivery Route Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Ophthalmic Drug Delivery Systems Market by Delivery Route Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Intraocular
5.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
5.5.2. Intravitreal
5.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
5.5.3. Intracameral
5.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
5.1.1. Intraocular
5.1.2. Intravitreal
5.1.3. Intracameral
5.2. Delivery Route Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Ophthalmic Drug Delivery Systems Market by Delivery Route Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Intraocular
5.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
5.5.2. Intravitreal
5.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
5.5.3. Intracameral
5.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
Chapter 6. Ophthalmic Drug Delivery Systems Market: Production Technology Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Electrospinning
6.1.2. 3D printing
6.1.3. Extrusion
6.1.4. Formulation
6.1.5. Micro patterning
6.1.6. Compression molding
6.1.7. Others
6.2. Application Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Ophthalmic Drug Delivery Systems Market by Production Technology Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.5.1. Electrospinning
6.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.2. 3D Printing
6.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.3. Extrusion
6.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.4. Formulation
6.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.5. Micro patterning
6.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.6. Compression molding
6.5.6.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.7. Others
6.5.7.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.1.1. Electrospinning
6.1.2. 3D printing
6.1.3. Extrusion
6.1.4. Formulation
6.1.5. Micro patterning
6.1.6. Compression molding
6.1.7. Others
6.2. Application Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Ophthalmic Drug Delivery Systems Market by Production Technology Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.5.1. Electrospinning
6.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.2. 3D Printing
6.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.3. Extrusion
6.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.4. Formulation
6.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.5. Micro patterning
6.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.6. Compression molding
6.5.6.1. Market estimates and forecast 2017 to 2030 (USD Million)
6.5.7. Others
6.5.7.1. Market estimates and forecast 2017 to 2030 (USD Million)
Chapter 7. Ophthalmic Drug Delivery Systems Market: Material Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Liposomes
7.1.2. Collagen
7.1.3. PLA-PEG
7.1.4. PDO/PVA
7.1.5. Hydrogels
7.1.6. TMC
7.1.7. Polyorthoesters
7.1.8. PLGA
7.1.9. Polycaprolactone
7.1.10. Fatty acids
7.1.11. Others
7.2. Material Market Share, 2021 & 2030
7.3. Segment Dashboard
7.4. Global Ophthalmic Drug Delivery Systems Market by Material Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
7.5.1. Liposomes
7.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.2. Collagen
7.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.3. PLA-PEG
7.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.4. PDO/PVA
7.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.5. Hydrogels
7.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.6. TMC
7.5.6.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.7. Polyorthoesters
7.5.7.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.8. PLGA
7.5.8.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.9. Fatty acids
7.5.9.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.10. Others
7.5.10.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.1.1. Liposomes
7.1.2. Collagen
7.1.3. PLA-PEG
7.1.4. PDO/PVA
7.1.5. Hydrogels
7.1.6. TMC
7.1.7. Polyorthoesters
7.1.8. PLGA
7.1.9. Polycaprolactone
7.1.10. Fatty acids
7.1.11. Others
7.2. Material Market Share, 2021 & 2030
7.3. Segment Dashboard
7.4. Global Ophthalmic Drug Delivery Systems Market by Material Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
7.5.1. Liposomes
7.5.1.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.2. Collagen
7.5.2.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.3. PLA-PEG
7.5.3.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.4. PDO/PVA
7.5.4.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.5. Hydrogels
7.5.5.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.6. TMC
7.5.6.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.7. Polyorthoesters
7.5.7.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.8. PLGA
7.5.8.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.9. Fatty acids
7.5.9.1. Market estimates and forecast 2017 to 2030 (USD Million)
7.5.10. Others
7.5.10.1. Market estimates and forecast 2017 to 2030 (USD Million)
Chapter 8. Ophthalmic Drug Delivery Systems Market: Regional Estimates & Trend Analysis
8.1. Regional market share analysis, 2021 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Regional Market Share and Leading Players, 2021
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Latin America
8.4.5. Middle East and Africa
8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1. North America
8.5.2. Europe
8.5.3. Asia Pacific
8.5.4. Latin America
8.5.5. Middle East and Africa
8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030:
8.7. North America
8.7.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.7.2. U.S.
8.7.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.7.3. Canada
8.7.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8. Europe
8.8.1. U.K.
8.8.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.2. Germany
8.8.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.3. France
8.8.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.4. Italy
8.8.4.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.5. Spain
8.8.5.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.6. Russia
8.8.6.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9. Asia Pacific
8.9.1. China
8.9.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.2. Japan
8.9.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.3. India
8.9.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.4. Australia
8.9.4.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.5. South Korea
8.9.5.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.6. Singapore
8.9.6.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.10. Latin America
8.10.1. Brazil
8.10.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.10.2. Mexico
8.10.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.10.3. Argentina
8.10.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.11. MEA
8.11.1. Saudi Arabia
8.11.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.11.2. South Africa
8.11.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.11.3. UAE
8.11.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Regional Market Share and Leading Players, 2021
8.4.1. North America
8.4.2. Europe
8.4.3. Asia Pacific
8.4.4. Latin America
8.4.5. Middle East and Africa
8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.5.1. North America
8.5.2. Europe
8.5.3. Asia Pacific
8.5.4. Latin America
8.5.5. Middle East and Africa
8.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030:
8.7. North America
8.7.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.7.2. U.S.
8.7.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.7.3. Canada
8.7.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8. Europe
8.8.1. U.K.
8.8.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.2. Germany
8.8.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.3. France
8.8.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.4. Italy
8.8.4.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.5. Spain
8.8.5.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.8.6. Russia
8.8.6.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9. Asia Pacific
8.9.1. China
8.9.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.2. Japan
8.9.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.3. India
8.9.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.4. Australia
8.9.4.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.5. South Korea
8.9.5.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.9.6. Singapore
8.9.6.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.10. Latin America
8.10.1. Brazil
8.10.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.10.2. Mexico
8.10.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.10.3. Argentina
8.10.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.11. MEA
8.11.1. Saudi Arabia
8.11.1.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.11.2. South Africa
8.11.2.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
8.11.3. UAE
8.11.3.1. Market estimates and forecast, 2017-2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2021
9.3.4. Ocular Therapeutix Inc
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Allergan plc.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Santen Pharmaceutical Co. Ltd.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Envisia Therapeutics
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. pSivida
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Clearside Biomedical
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Oculis Pharma
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Valeant Pharmaceuticals
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. AptarGroup, Inc.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2021
9.3.4. Ocular Therapeutix Inc
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Allergan plc.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Santen Pharmaceutical Co. Ltd.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Envisia Therapeutics
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. pSivida
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Clearside Biomedical
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Oculis Pharma
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Valeant Pharmaceuticals
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. AptarGroup, Inc.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America ophthalmic drug Delivery systems market, by technology, 2017-2030 (USD Million)
Table 3 North America ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 4 North America ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 5 North America ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 6 North America ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 7 U.S. ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 8 U.S. ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 9 U.S. ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 10 U.S. ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 11 Canada ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 12 Canada ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 13 Canada ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 14 Canada ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 15 Europe ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 16 Europe ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 17 Europe ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 18 Europe ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 19 Europe ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 20 Germany ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 21 Germany ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 22 Germany ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 23 Germany ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 24 U.K. ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 25 U.K. ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 26 U.K. ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 27 U.K. ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 28 France ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 29 France ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 30 France ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 31 France ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 32 Italy ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 33 Italy ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 34 Italy ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 35 Italy ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 36 Spain ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 37 Spain ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 38 Spain ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 39 Spain ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 40 Russia ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 41 Russia ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 42 Russia ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 43 Russia ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 44 APAC ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 45 APAC ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 46 APAC ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 47 APAC ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 48 APAC ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 49 China ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 50 China ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 51 China ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 52 China ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 53 Japan ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 54 Japan ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 55 Japan ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 56 Japan ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 57 India ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 58 India ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 59 India ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 60 India ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 61 Australia ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 62 Australia ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 63 Australia ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 64 Australia ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 65 South Korea ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 66 South Korea ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 67 South Korea ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 68 South Korea ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 69 Singapore ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 70 Singapore ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 71 Singapore ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 72 Singapore ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 73 Latin America ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 74 Latin America ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 75 Latin America ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 76 Latin America ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 77 Latin America ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 78 Brazil ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 79 Brazil ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 80 Brazil ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 81 Brazil ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 82 Mexico ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 83 Mexico ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 84 Mexico ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 85 Mexico ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 86 Argentina ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 87 Argentina ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 88 Argentina ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 89 Argentina ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 90 Middle East and Africa ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 91 Middle East and Africa ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 92 Middle East and Africa ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 93 Middle East and Africa ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 94 Middle East and Africa ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 95 South Africa ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 96 South Africa ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 97 South Africa ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 98 South Africa ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 99 Saudi Arabia ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 100 Saudi Arabia ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 101 Saudi Arabia ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 102 Saudi Arabia ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 103 UAE ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 104 UAE ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 105 UAE ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 106 UAE ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 2 North America ophthalmic drug Delivery systems market, by technology, 2017-2030 (USD Million)
Table 3 North America ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 4 North America ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 5 North America ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 6 North America ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 7 U.S. ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 8 U.S. ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 9 U.S. ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 10 U.S. ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 11 Canada ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 12 Canada ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 13 Canada ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 14 Canada ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 15 Europe ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 16 Europe ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 17 Europe ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 18 Europe ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 19 Europe ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 20 Germany ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 21 Germany ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 22 Germany ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 23 Germany ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 24 U.K. ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 25 U.K. ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 26 U.K. ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 27 U.K. ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 28 France ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 29 France ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 30 France ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 31 France ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 32 Italy ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 33 Italy ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 34 Italy ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 35 Italy ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 36 Spain ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 37 Spain ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 38 Spain ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 39 Spain ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 40 Russia ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 41 Russia ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 42 Russia ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 43 Russia ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 44 APAC ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 45 APAC ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 46 APAC ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 47 APAC ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 48 APAC ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 49 China ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 50 China ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 51 China ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 52 China ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 53 Japan ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 54 Japan ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 55 Japan ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 56 Japan ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 57 India ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 58 India ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 59 India ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 60 India ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 61 Australia ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 62 Australia ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 63 Australia ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 64 Australia ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 65 South Korea ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 66 South Korea ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 67 South Korea ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 68 South Korea ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 69 Singapore ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 70 Singapore ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 71 Singapore ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 72 Singapore ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 73 Latin America ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 74 Latin America ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 75 Latin America ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 76 Latin America ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 77 Latin America ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 78 Brazil ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 79 Brazil ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 80 Brazil ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 81 Brazil ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 82 Mexico ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 83 Mexico ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 84 Mexico ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 85 Mexico ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 86 Argentina ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 87 Argentina ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 88 Argentina ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 89 Argentina ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 90 Middle East and Africa ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 91 Middle East and Africa ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 92 Middle East and Africa ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 93 Middle East and Africa ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 94 Middle East and Africa ophthalmic drug delivery systems market, by region, 2017-2030 (USD Million)
Table 95 South Africa ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 96 South Africa ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 97 South Africa ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 98 South Africa ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 99 Saudi Arabia ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 100 Saudi Arabia ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 101 Saudi Arabia ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 102 Saudi Arabia ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
Table 103 UAE ophthalmic drug delivery systems market, by technology, 2017-2030 (USD Million)
Table 104 UAE ophthalmic drug delivery systems market, by delivery route, 2017-2030 (USD Million)
Table 105 UAE ophthalmic drug delivery systems market, by production technology, 2017-2030 (USD Million)
Table 106 UAE ophthalmic drug delivery systems market, by material, 2017-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Ophthalmic drug delivery systems: market outlook
Fig. 14 Ophthalmic drug delivery systems competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Ophthalmic drug delivery systems market driver impact
Fig. 20 Ophthalmic drug delivery systems market restraint impact
Fig. 21 Ophthalmic drug delivery systems market strategic initiatives analysis
Fig. 22 Ophthalmic drug delivery systems market: technology movement analysis
Fig. 23 Ophthalmic drug delivery systems market: technology outlook and key takeaways
Fig. 24 Ophthalmic drug delivery systems market estimates and forecast, 2017 - 2030
Fig. 25 Eye drops market estimates and forecast, 2017 - 2030
Fig. 26 Contact lenses market estimates and forecast, 2017 - 2030
Fig. 27 Punctal plugs market estimates and forecast, 2017 - 2030
Fig. 28 Episcleral implants market estimates and forecast, 2017 - 2030
Fig. 29 Intravitreal implants market estimates and forecast, 2017 - 2030
Fig. 30 InjecTable particulate systems market estimates and forecast, 2017 - 2030
Fig. 31 Iontophoresis market estimates and forecast, 2017 - 2030
Fig. 32 Micro-Electromechanical market estimates and forecast, 2017 - 2030
Fig. 33 Nano careers market estimates and forecast, 2017 - 2030
Fig. 34 Nano microparticles market estimates and forecast, 2017 - 2030
Fig. 35 Microneedles market estimates and forecast, 2017 - 2030
Fig. 36 Hydrogels market estimates and forecast, 2017 - 2030
Fig. 37 Others market estimates and forecast, 2017 - 2030
Fig. 38 Ophthalmic drug delivery systems market: delivery route movement analysis
Fig. 39 Ophthalmic drug delivery systems market: delivery route outlook and key takeaways
Fig. 40 Intraocular market estimates and forecast, 2017 - 2030
Fig. 41 Intravitreal market estimates and forecast, 2017 - 2030
Fig. 42 Intracameral market estimates and forecast, 2017 - 2030
Fig. 43 Ophthalmic drug delivery systems market: production technology movement analysis
Fig. 44 Ophthalmic drug delivery systems market: production technology outlook and key takeaways
Fig. 45 Electrospinning market estimates and forecast, 2017 - 2030
Fig. 46 3D printing market estimates and forecast, 2017 - 2030
Fig. 47 Formulation market estimates and forecast, 2017 - 2030
Fig. 48 Micro patterning market estimates and forecast, 2017 - 2030
Fig. 49 Compression molding market estimates and forecast, 2017 - 2030
Fig. 50 Others market estimates and forecast, 2017 - 2030
Fig. 51 Ophthalmic drug delivery systems market: material movement analysis
Fig. 52 Ophthalmic drug delivery systems market: material outlook and key takeaways
Fig. 53 Liposomes market estimates and forecast, 2017 - 2030
Fig. 54 Collagen market estimates and forecast, 2017 - 2030
Fig. 55 PLA-PEG market estimates and forecast, 2017 - 2030
Fig. 56 PDO/PVA market estimates and forecast, 2017 - 2030
Fig. 57 Hydrogels market estimates and forecast, 2017 - 2030
Fig. 58 TMC market estimates and forecast, 2017 - 2030
Fig. 59 Polyorthoesters market estimates and forecast, 2017 - 2030
Fig. 60 PLGA market estimates and forecast, 2017 - 2030
Fig. 61 Polycaprolactone market estimates and forecast, 2017 - 2030
Fig. 62 Fatty acids market estimates and forecast, 2017 - 2030
Fig. 63 Others market estimates and forecast, 2017 - 2030
Fig. 64 Global ophthalmic drug delivery systems market: regional movement analysis
Fig. 65 Global ophthalmic drug delivery systems market: regional outlook and key takeaways
Fig. 66 Global market share and leading players
Fig. 67 North America market share and leading players
Fig. 68 Europe market share and leading players
Fig. 69 Asia Pacific market share and leading players
Fig. 70 Latin America market share and leading players
Fig. 71 Middle East & Africa market share and leading players
Fig. 72 North America: SWOT
Fig. 73 Europe SWOT
Fig. 74 Asia Pacific SWOT
Fig. 75 Latin America SWOT
Fig. 76 MEA SWOT
Fig. 77 North America, by country
Fig. 78 North America
Fig. 79 North America market estimates and forecast, 2017 - 2030
Fig. 80 U.S.
Fig. 81 U.S. market estimates and forecast, 2017 - 2030
Fig. 82 Canada
Fig. 83 Canada market estimates and forecast, 2017 - 2030
Fig. 84 Europe
Fig. 85 Europe market estimates and forecast, 2017 - 2030
Fig. 86 U.K.
Fig. 87 U.K. market estimates and forecast, 2017 - 2030
Fig. 88 Germany
Fig. 89 Germany market estimates and forecast, 2017 - 2030
Fig. 90 France
Fig. 91 France market estimates and forecast, 2017 - 2030
Fig. 92 Italy
Fig. 93 Italy market estimates and forecast, 2017 - 2030
Fig. 94 Spain
Fig. 95 Spain market estimates and forecast, 2017 - 2030
Fig. 96 Russia
Fig. 97 Russia market estimates and forecast, 2017 - 2030
Fig. 98 Asia Pacific
Fig. 99 Asia Pacific market estimates and forecast, 2017 - 2030
Fig. 100 China
Fig. 101 China market estimates and forecast, 2017 - 2030
Fig. 102 Japan
Fig. 103 Japan market estimates and forecast, 2017 - 2030
Fig. 104 India
Fig. 105 India market estimates and forecast, 2017 - 2030
Fig. 106 Australia
Fig. 107 Australia market estimates and forecast, 2017 - 2030
Fig. 108 South Korea
Fig. 109 South Korea market estimates and forecast, 2017 - 2030
Fig. 110 Singapore
Fig. 111 Singapore market estimates and forecast, 2017 - 2030
Fig. 112 Latin America
Fig. 113 Latin America market estimates and forecast, 2017 - 2030
Fig. 114 Brazil
Fig. 115 Brazil market estimates and forecast, 2017 - 2030
Fig. 116 Mexico
Fig. 117 Mexico market estimates and forecast, 2017 - 2030
Fig. 118 Argentina
Fig. 119 Argentina market estimates and forecast, 2017 - 2030
Fig. 120 Middle East and Africa
Fig. 121 Middle East and Africa market estimates and forecast, 2017 - 2030
Fig. 122 Saudi Arabia
Fig. 123 Saudi Arabia market estimates and forecast, 2017 - 2030
Fig. 124 South Africa
Fig. 125 South Africa market estimates and forecast, 2017 - 2030
Fig. 126 UAE
Fig. 127 UAE market estimates and forecast, 2017 - 2030
Fig. 128 Participant categorization- ophthalmic drug delivery systems market
Fig. 129 Market share of key market players- Ophthalmic drug delivery systems market
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Ophthalmic drug delivery systems: market outlook
Fig. 14 Ophthalmic drug delivery systems competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Ophthalmic drug delivery systems market driver impact
Fig. 20 Ophthalmic drug delivery systems market restraint impact
Fig. 21 Ophthalmic drug delivery systems market strategic initiatives analysis
Fig. 22 Ophthalmic drug delivery systems market: technology movement analysis
Fig. 23 Ophthalmic drug delivery systems market: technology outlook and key takeaways
Fig. 24 Ophthalmic drug delivery systems market estimates and forecast, 2017 - 2030
Fig. 25 Eye drops market estimates and forecast, 2017 - 2030
Fig. 26 Contact lenses market estimates and forecast, 2017 - 2030
Fig. 27 Punctal plugs market estimates and forecast, 2017 - 2030
Fig. 28 Episcleral implants market estimates and forecast, 2017 - 2030
Fig. 29 Intravitreal implants market estimates and forecast, 2017 - 2030
Fig. 30 InjecTable particulate systems market estimates and forecast, 2017 - 2030
Fig. 31 Iontophoresis market estimates and forecast, 2017 - 2030
Fig. 32 Micro-Electromechanical market estimates and forecast, 2017 - 2030
Fig. 33 Nano careers market estimates and forecast, 2017 - 2030
Fig. 34 Nano microparticles market estimates and forecast, 2017 - 2030
Fig. 35 Microneedles market estimates and forecast, 2017 - 2030
Fig. 36 Hydrogels market estimates and forecast, 2017 - 2030
Fig. 37 Others market estimates and forecast, 2017 - 2030
Fig. 38 Ophthalmic drug delivery systems market: delivery route movement analysis
Fig. 39 Ophthalmic drug delivery systems market: delivery route outlook and key takeaways
Fig. 40 Intraocular market estimates and forecast, 2017 - 2030
Fig. 41 Intravitreal market estimates and forecast, 2017 - 2030
Fig. 42 Intracameral market estimates and forecast, 2017 - 2030
Fig. 43 Ophthalmic drug delivery systems market: production technology movement analysis
Fig. 44 Ophthalmic drug delivery systems market: production technology outlook and key takeaways
Fig. 45 Electrospinning market estimates and forecast, 2017 - 2030
Fig. 46 3D printing market estimates and forecast, 2017 - 2030
Fig. 47 Formulation market estimates and forecast, 2017 - 2030
Fig. 48 Micro patterning market estimates and forecast, 2017 - 2030
Fig. 49 Compression molding market estimates and forecast, 2017 - 2030
Fig. 50 Others market estimates and forecast, 2017 - 2030
Fig. 51 Ophthalmic drug delivery systems market: material movement analysis
Fig. 52 Ophthalmic drug delivery systems market: material outlook and key takeaways
Fig. 53 Liposomes market estimates and forecast, 2017 - 2030
Fig. 54 Collagen market estimates and forecast, 2017 - 2030
Fig. 55 PLA-PEG market estimates and forecast, 2017 - 2030
Fig. 56 PDO/PVA market estimates and forecast, 2017 - 2030
Fig. 57 Hydrogels market estimates and forecast, 2017 - 2030
Fig. 58 TMC market estimates and forecast, 2017 - 2030
Fig. 59 Polyorthoesters market estimates and forecast, 2017 - 2030
Fig. 60 PLGA market estimates and forecast, 2017 - 2030
Fig. 61 Polycaprolactone market estimates and forecast, 2017 - 2030
Fig. 62 Fatty acids market estimates and forecast, 2017 - 2030
Fig. 63 Others market estimates and forecast, 2017 - 2030
Fig. 64 Global ophthalmic drug delivery systems market: regional movement analysis
Fig. 65 Global ophthalmic drug delivery systems market: regional outlook and key takeaways
Fig. 66 Global market share and leading players
Fig. 67 North America market share and leading players
Fig. 68 Europe market share and leading players
Fig. 69 Asia Pacific market share and leading players
Fig. 70 Latin America market share and leading players
Fig. 71 Middle East & Africa market share and leading players
Fig. 72 North America: SWOT
Fig. 73 Europe SWOT
Fig. 74 Asia Pacific SWOT
Fig. 75 Latin America SWOT
Fig. 76 MEA SWOT
Fig. 77 North America, by country
Fig. 78 North America
Fig. 79 North America market estimates and forecast, 2017 - 2030
Fig. 80 U.S.
Fig. 81 U.S. market estimates and forecast, 2017 - 2030
Fig. 82 Canada
Fig. 83 Canada market estimates and forecast, 2017 - 2030
Fig. 84 Europe
Fig. 85 Europe market estimates and forecast, 2017 - 2030
Fig. 86 U.K.
Fig. 87 U.K. market estimates and forecast, 2017 - 2030
Fig. 88 Germany
Fig. 89 Germany market estimates and forecast, 2017 - 2030
Fig. 90 France
Fig. 91 France market estimates and forecast, 2017 - 2030
Fig. 92 Italy
Fig. 93 Italy market estimates and forecast, 2017 - 2030
Fig. 94 Spain
Fig. 95 Spain market estimates and forecast, 2017 - 2030
Fig. 96 Russia
Fig. 97 Russia market estimates and forecast, 2017 - 2030
Fig. 98 Asia Pacific
Fig. 99 Asia Pacific market estimates and forecast, 2017 - 2030
Fig. 100 China
Fig. 101 China market estimates and forecast, 2017 - 2030
Fig. 102 Japan
Fig. 103 Japan market estimates and forecast, 2017 - 2030
Fig. 104 India
Fig. 105 India market estimates and forecast, 2017 - 2030
Fig. 106 Australia
Fig. 107 Australia market estimates and forecast, 2017 - 2030
Fig. 108 South Korea
Fig. 109 South Korea market estimates and forecast, 2017 - 2030
Fig. 110 Singapore
Fig. 111 Singapore market estimates and forecast, 2017 - 2030
Fig. 112 Latin America
Fig. 113 Latin America market estimates and forecast, 2017 - 2030
Fig. 114 Brazil
Fig. 115 Brazil market estimates and forecast, 2017 - 2030
Fig. 116 Mexico
Fig. 117 Mexico market estimates and forecast, 2017 - 2030
Fig. 118 Argentina
Fig. 119 Argentina market estimates and forecast, 2017 - 2030
Fig. 120 Middle East and Africa
Fig. 121 Middle East and Africa market estimates and forecast, 2017 - 2030
Fig. 122 Saudi Arabia
Fig. 123 Saudi Arabia market estimates and forecast, 2017 - 2030
Fig. 124 South Africa
Fig. 125 South Africa market estimates and forecast, 2017 - 2030
Fig. 126 UAE
Fig. 127 UAE market estimates and forecast, 2017 - 2030
Fig. 128 Participant categorization- ophthalmic drug delivery systems market
Fig. 129 Market share of key market players- Ophthalmic drug delivery systems market
Companies Mentioned
- Ocular Therapeutix Inc
- Allergan plc.
- Santen Pharmaceutical Co. Ltd.
- Envisia Therapeutics
- pSivida
- Clearside Biomedical
- Oculis Pharma
- Valeant Pharmaceuticals
- AptarGroup, Inc.
Methodology
LOADING...
